Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1[beta] production and deficient apoptosis of rheumatoid arthritis monocytes
Arthritis & Rheumatism, 09/01/09
Meusch U et al. – Outside-to-inside signaling through transmembrane TNF after ligation by infliximab inhibits constitutive NF-B activation and suppresses spontaneous IL-1 production by monocytes from patients with RA.
Methods- Peripheral blood monocytes from patients with RA and healthy control subjects were incubated in the presence of anti-TNF antibody or IgG
- Annexin V staining, caspase activation, poly(ADP-ribose) polymerase cleavage, and DNA staining with propidium iodide were used to analyze apoptosis
- The signaling events elicited in monocytes by infliximab were analyzed by Western blotting and electromobility shift assay
- Peripheral blood monocytes from patients with RA were characterized by increased expression of transmembrane TNF, spontaneous in vitro production of interleukin-1 (IL-1), and a decreased rate of spontaneous ex vivo apoptosis
- Incubation with infliximab induced significantly increased apoptosis in monocytes from patients with RA but not in monocytes from healthy control subjects
- This apoptosis was triggered by reverse signaling of transmembrane TNF after ligation by infliximab and was independent of caspase activation. Instead, transmembrane TNF reverse signaling inhibited the constitutive NF-B activation in RA monocytes, suppressed IL-1 secretion, and normalized spontaneous in vitro apoptosis
- This normalization was reversible by the addition of exogenous IL-1
Related Articles
Monocyte derived interleukin (IL)-23 is an important determinant of synovial Il-17A expression in rheumatoid arthritis
Journal of Rheumatology, 10/05/09
Relevance Score: 80%%
Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis
Rheumatology, 10/16/09
Relevance Score: 79%%
TNF{alpha} blockade impairs dendritic cell survival and function in rheumatoid arthritis [Extended Report]
Annals of Rheumatic Diseases, 10/07/09
Relevance Score: 79%%
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 71%%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 70%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Plasma level of myeloperoxidase in children with juvenile idiopathic arthritis (a pilot study)
Central European Journal of Medicine, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis
International Journal of Rheumatic Diseases, 11/25/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production
Arthritis Research & Therapy, 11/25/09
Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis
Annals of Rheumatic Diseases, 11/24/09
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis
Annals of Rheumatic Diseases, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


